CD20+ Follicular Lymphoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB11952Duvelisib1 / 2Terminated1
DB08935Obinutuzumab1 / 2Terminated1
DB00073Rituximab1 / 2Terminated1